Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Miki

Showing results (121-130 of 230) with videos related to

Pageof 23
Sort By:
Cancer Science|May 28, 2014
GATA4 immunolocalization in breast carcinoma as a potent prognostic predictorKiyoshi Takagi, Takashi Moriguchi, Yasuhiro Miki, et al.
The Journal of Steroid Biochemistry and Molecular Biology|August 29, 2003
The possible roles of mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 2 in cardiac fibrosis in the spontaneously hypertensive ratAkinobu Konishi, Chika Tazawa, Yasuhiro Miki, et al.
Pathology International|October 10, 2007
Decreased expression of RIZ1 and its clinicopathological significance in epithelial ovarian carcinoma: correlation with epigenetic inactivation by aberrant DNA methylationJun-Ichi Akahira, Fumihiko Suzuki, Takashi Suzuki, et al.
Anticancer Research|April 3, 2014
Activation of AXL and antitumor effects of a monoclonal antibody to AXL in lung adenocarcinomaShinya Iida, Yasuhiro Miki, Takashi Suzuki, et al.
Cancers|November 9, 2024
Receptor for Hyaluronan Mediated Motility (RHAMM)/Hyaluronan Axis in Breast Cancer ChemoresistanceShiori Fujisawa, Kiyoshi Takagi, Mio Yamaguchi-Tanaka, et al.
Cancer Science|March 16, 2007
Nuclear cyclin B1 in human breast carcinoma as a potent prognostic factorTakashi Suzuki, Tomohiro Urano, Yasuhiro Miki, et al.
The Journal of Steroid Biochemistry and Molecular Biology|June 20, 2025
5α-reductase type 3 is a predictive marker for chemotherapy efficacy in breast cancer in an androgen-independent mannerKanoko Nakamura, Kiyoshi Takagi, Mio Yamaguchi-Tanaka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2009
Local biosynthesis of estrogen in human endometrial carcinoma through tumor-stromal cell interactionsNaomi Takahashi-Shiga, Hiroki Utsunomiya, Yasuhiro Miki, et al.
International Journal of Molecular Sciences|May 13, 2023
Kallikrein-Related Peptidase 12 (KLK12) in Breast Cancer as a Favorable Prognostic MarkerAi Sato, Kiyoshi Takagi, Ayano Yoshimura, et al.
Cancer Research|February 5, 2009
17Beta-hydroxysteroid dehydrogenase type 12 in human breast carcinoma: a prognostic factor via potential regulation of fatty acid synthesisShuji Nagasaki, Takashi Suzuki, Yasuhiro Miki, et al.
Pageof 23

Showing results (121-130 of 230) with videos related to

Sort By:
Pageof 23
Cancer Science|May 28, 2014
GATA4 immunolocalization in breast carcinoma as a potent prognostic predictorKiyoshi Takagi, Takashi Moriguchi, Yasuhiro Miki, et al.
The Journal of Steroid Biochemistry and Molecular Biology|August 29, 2003
The possible roles of mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 2 in cardiac fibrosis in the spontaneously hypertensive ratAkinobu Konishi, Chika Tazawa, Yasuhiro Miki, et al.
Pathology International|October 10, 2007
Decreased expression of RIZ1 and its clinicopathological significance in epithelial ovarian carcinoma: correlation with epigenetic inactivation by aberrant DNA methylationJun-Ichi Akahira, Fumihiko Suzuki, Takashi Suzuki, et al.
Anticancer Research|April 3, 2014
Activation of AXL and antitumor effects of a monoclonal antibody to AXL in lung adenocarcinomaShinya Iida, Yasuhiro Miki, Takashi Suzuki, et al.
Cancers|November 9, 2024
Receptor for Hyaluronan Mediated Motility (RHAMM)/Hyaluronan Axis in Breast Cancer ChemoresistanceShiori Fujisawa, Kiyoshi Takagi, Mio Yamaguchi-Tanaka, et al.
Cancer Science|March 16, 2007
Nuclear cyclin B1 in human breast carcinoma as a potent prognostic factorTakashi Suzuki, Tomohiro Urano, Yasuhiro Miki, et al.
The Journal of Steroid Biochemistry and Molecular Biology|June 20, 2025
5α-reductase type 3 is a predictive marker for chemotherapy efficacy in breast cancer in an androgen-independent mannerKanoko Nakamura, Kiyoshi Takagi, Mio Yamaguchi-Tanaka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2009
Local biosynthesis of estrogen in human endometrial carcinoma through tumor-stromal cell interactionsNaomi Takahashi-Shiga, Hiroki Utsunomiya, Yasuhiro Miki, et al.
International Journal of Molecular Sciences|May 13, 2023
Kallikrein-Related Peptidase 12 (KLK12) in Breast Cancer as a Favorable Prognostic MarkerAi Sato, Kiyoshi Takagi, Ayano Yoshimura, et al.
Cancer Research|February 5, 2009
17Beta-hydroxysteroid dehydrogenase type 12 in human breast carcinoma: a prognostic factor via potential regulation of fatty acid synthesisShuji Nagasaki, Takashi Suzuki, Yasuhiro Miki, et al.
Pageof 23